Synjardy manufacturer?

Who makes Synjardy (and what company sells it)?

Synjardy is a brand-name diabetes medicine made by Boehringer Ingelheim Pharmaceuticals, Inc. (often referred to as “Boehringer Ingelheim”) in the U.S. [1].

Is Synjardy the same as Synjardy XR? Who makes each?

Synjardy and Synjardy XR are both marketed by Boehringer Ingelheim. The “XR” version is the extended-release formulation, but the manufacturer/sponsor is the same company. [1]

Are there other “Synjardy” products or related generics?

Synjardy (and Synjardy XR) may have FDA-approved generic versions depending on the ingredient(s) and formulation. The brand-name manufacturer is still Boehringer Ingelheim. For any specific generic or combination product, check the exact FDA label/manufacturer listed on the packaging or the drug’s FDA entry. [1]

What are the active ingredients in Synjardy?

Synjardy combines two diabetes medicines: empagliflozin and metformin. Synjardy XR also uses empagliflozin and metformin, but in an extended-release format. [1]

Can patents or exclusivity affect who makes it?

Brand marketing exclusivity and patents can influence when alternatives (like generics) enter, though the “manufacturer” of the brand product remains Boehringer Ingelheim. Patent/exclusivity details vary by product and formulation; DrugPatentWatch tracks related patent information. [2]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020765
[2] https://www.drugpatentwatch.com/